期刊文献+

染料法腋窝反向淋巴作图300例临床研究 被引量:8

Axillary reverse mapping by dye method in 300 breast cancer patients
下载PDF
导出
摘要 目的:研究腋窝反向淋巴作图(axillary reverse mapping,ARM)对上肢淋巴回流管网的辨别和保护作用及对减少腋窝淋巴结清扫术后上肢水肿的作用。方法:选取2009年6月至2011年5月蚌埠医学院第一附属医院肿瘤外三科300例单侧乳腺癌患者,在进行腋窝淋巴结清扫前,经上臂内侧肌间沟皮下注射亚甲蓝2~3mL,对上肢来源的淋巴管和淋巴结进行染色,术中加以辨别和保护。术后2个月测量双上臂周径差异(患侧臂周径一健侧臂周径≥2cm为淋巴水肿),记录淋巴水肿的发生情况。结果:300例患者中有195例作图成功,成功率65%。分别于术后6、12、18、24个月进行随访,发现和同期作图失败患者相比较,作图成功患者淋巴水肿的发生率明显降低,差异具有显著性统计学意义。结论:通过腋窝反向淋巴作图(ARM)可以辨别保护上肢回流的淋巴管道,对预防乳腺癌腋窝淋巴结清扫术后上肢水肿具有临床意义。 Objective: To assess the ability of axillary reverse mapping (ARM) to identify and preserve the arm lymphatics drainage as well as determine its ability to reduce lymphedema. Methods: A total of 300 breast cancer patients who underwent axillary lymph node dissection (ALND) from June 2009 to May 2011 were enrolled in this study. Methylene blue dye (2 mL to 3 mL) was injected into the ipsilateral upper inner arm along the medial intramuscular groove to map the upper extremity lymphatic drainage system prior to ALND. The blue lymphatic and lymph nodes were identified and preserved during the operation. The change in the arm circumference was the selected method of measurement. The difference in the bilateral upper arm circumference was recorded after 2 months (difference ≥ 2 cm is defined as lymphedema). Results: The ARM was performed successfully in 195 (65%) of 300 patients. The incidence of lymphedema was significantly lower in the successfully mapped patients than in the failing mapping patients, with statistically significant difference during follow-up at 6, 12, 18, and 24 months post operation. Conclusion: The ARM technique can identify and preserve the arm lymphatics drainage and prevent upper extremity lymphedema after breast cancer axillary lymphadenectomy.
出处 《中国肿瘤临床》 CAS CSCD 北大核心 2013年第21期1296-1299,共4页 Chinese Journal of Clinical Oncology
关键词 腋窝反向作图 乳腺癌 腋窝淋巴清扫 淋巴水肿 axillary reverse mapping, breast cancer, axillary lymph node dissection, lymphedema
  • 相关文献

参考文献17

  • 1RoSa R, von Smitten K, Tasmuth T, et al. One-year morbidity af- ter sentinel node biopsy and breast surgery[J]. Breast, 2005, 14(1): 28-36.
  • 2Leidenius M, Leivonen M, Vironen J, et al. The consequences of long-time arm morbidity in node-negative breast cancer patients with sentinel node biopsy or axillary clearance[J]. Surg Oncol, 2005, 92 (1) :23-31.
  • 3Wilke LG, McCall LM, Posther KE, et al. Surgical complication-sas-sociated with sentinel lymph node biopsy:results from a pro- spective international cooperative group trial[J]. Ann Surg Oncol, 2006, 13(4):491-500.
  • 4Sakorafas GH, Peros G, Cataliotti L, et al. Lymphedema following axillary lymph node dissection for breast cancer[J]. Surg Oncol, 2006, 15(3):153-165.
  • 5Klimberg VS. A new concept toward the prevention of lymphede- ma:axiUary reverse mapping[J]. Surg Oncol, 2008, 97(7):563-564.
  • 6Suami H, Taylor GI, Pan WR. The lymphatic territories of the up- per limb:anatomical study and clinical implications[J]. Plast Recon- str Surg, 2007, 119(6):1813-1822.
  • 7Suami H, Pan WR, Taylor GI. Changes in the lymph structure of the upper limb after axillary dissection:radiographic an d anatomi- cal study in a human cadaver[J]. Plast Reconstr Surg, 2007, 120(4): 982-991.
  • 8Thompson M, Komufian S, Henry-Tillman R, et al. AxiUary re- verse mapping(ARM):a new concept to identify and enhance lym- phatic preservation[J]. Ann Surg Oncol, 2008, 14(6):1890-1895.
  • 9Nos C, Lesieur B, Clough K.B, et al. Blue dye injection in the arm in order to conserve the lymphatic drainage of the arm in breast can- cer patients requiring an axillary dissection[J]. Ann Surg Oncol, 2007, 14(9):2490-2496.
  • 10Boneti C, Korourian S, Bland K, et al. Axillary reverse mapping: mapping and preserving ann lymphatics may be important in pre- venting lymphedema during sentinel lymph node biopsy[J]. J Am Coll Surg, 2008, 206(5):1038-1044.

二级参考文献12

  • 1Johansson K, Branje E. Arm lymphoedema in a cohort of breast cancer survivors 10 years after diagnosis [ J ]. Acta Oncol, 2010,49 (2) : 166-173.
  • 2Park JH, Lee WH, Chung HS. Incidence and risk factors of breast cancer lymphoedema[ J ]. Clin Nurs ,2008,17( 11 ) : 1450-1459.
  • 3Hayes SC,Janda M,Cornish B,et al. Lymphedema after breast cancer:incidence,risk factors,and effect on upper body function [J]. Clin Oncol, 2008,26(21 ) : 3536-3542.
  • 4Golshan M, Smith B. Prevention and management of arm lymphedema in the patient with breast cancer [ J ]. Support Oncol, 2006,4 (8) : 381 - 386.
  • 5Armer JM. The problem of post-breast cancer lymphedema:impact and measurement issues[ J ]. Gerontol Nurs, 2005,31 (5) : 29-39.
  • 6] Hinrichs CS,Watroba NL,Rezaishiraz H,et al. Lymphedema secondary to postmastectomy radiation:incidence and risk factors [J ]. Ann Surg Oncol, 2004, 11 (6) : 573-580.
  • 7Hayes SB,Freedman GM, Li T, et al. Does axillary boost increase lymphedema compared with supraclavicular radiation alone after breast conservation? [J 1. Int J Radiat Oncol Biol Phys, 2008,72 (5): 1449-1455.
  • 8Purushotham AD, Bennett Britton TM, Klevesath MB, et al. Lymph node status and breast cancer-related lymphedema [J]. Ann Surg, 2007,246( 1 ) : 42-45.
  • 9Sakorafas GH, Peros G, Cataliotti L, et al. Lymphedema following axillary lymph node dissection for breast cancer[J]. Surg Oncol,2006, 15(3) : 153-165.
  • 10Vignes S,Arrault M, Dupuy A. Factors associated with increased breast cancer-related lymphedema volume [J]. Acta Oncol,2007, 46(8) : 1138-1142.

共引文献52

同被引文献59

  • 1张明亮,张晓静,田怀杲,王益民,孙医学,葛侠.染料法腋窝反向淋巴作图在早期乳腺癌手术中的应用及分析[J].肿瘤防治研究,2014,41(5):452-455. 被引量:9
  • 2McLaughlin SA. Lymphedema: separating fact from fiction [j].Oncology (Williston Park),2012,26(3):242-249.
  • 3International Society of Lymphology. The diagnosis and treat-ment of peripheral lympherlema.2009 Concensus Document ofthe International Society of Lymphology [j], Lymphology, 2009,42(2):51-60.
  • 4Vander Vorst JR,Schaafsma BE, Verbeek FP,et al. Randomizedcomparison of near-infrared fluorescrence imaging using indocy-anine green and 99(m) technetium with or without patent blue forthe sentinel lymph node procedure in breast cancer patients [j].Ann Surg Oncol,2012,19(13):4104-4111.
  • 5Casabona F, Boglioio S, Vaienzano Menada M, et al. Feasibilityof axillary reverse mapping during sentinel lymph node biopsy inbreast cancer patients [j]. Ann Surg Oncol, 2009, 16(9):2459-2463.
  • 6Gobardhan PD, Wijsman JH, van DalenT, et al. ARM: axillaryreverse mapping - the need for selection of patients [j]. Eur JSurg Oncol,2012,38(8):657-661.
  • 7Han JW, Seo YJ, Choi JE, et al. The efficacy of arm node pre-serving surgery using axillary reverse mapping for preventinglymphedema in patients with breast cancer[j]. J Breast Cancer,2012,15(1):91-97.
  • 8Deng H, Chen L, Jia W, et al. Safety study of axillary reversemapping in the surgical treatment for breast cancer patients [j].J Cancer Res Clin Oncol,2011,137(12):1869-1874.
  • 9Boneti C,Badgwell B,Robertson Y,et al. Axillary reverse map-ping (ARM): initial results of phase II trial in preventing lymph-edema after lymphadenentomy [J]. Minerva Ginecol, 2012, 64(5):421-430.
  • 10McLanghlin SA. Lymphedema: separating fact from fiction [ J ]. Oncolagy (Williston Park), 2012, 26(3): 242-249.

引证文献8

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部